2010-02-25 Call Agenda

To return to the >> Oncology EHR Functional Profile or Agendas and Minutes

HL7 Ambulatory Oncology Functional Profile Meeting

Meeting Logistics

Date/Time: Thursday, February 25, 2010 / 1:00 PM – 3:00 PM EST

Location: Telecon 866 564 2805 x9306830#

Attendees

Agenda

1. Welcome and Introductions
2. Agenda review and approval
3. Approval of minutes from previous calls: February 11th, Janusry 28th and January 14th
4. Upcoming call schedule
   • Helen is unavailable for the next scheduled call (March 11th)
   • Do we need to move to weekly calls for March - given ballot deadline of April 8th?
5. Review Actions from previous meeting(s)

   February 11th Call

   1. ACTION: Helen will discuss the DrohanHughes2009BreastModularEHR.pdf with the caEHR project team at the NCI and provide comment back to the team on how this relates to the NCI architectural plans.
   2. ACTION: Dr. Hughes will draft some language about interoperability with the HL7 Genomics standards that can be incorporated into the Patient History section of the functional profile.
   3. ACTION: Marla will write some specifics around pediatric oncology, items that are unique to pediatrics or how the scope of practice is defined. Take into consideration any adjustment any change we need to make to the profile.
   4. ACTION: Christine to develop scope/introductory language on Geriatric Oncology with Dr. John.
   5. ACTION: All team members to review glossary and submit changes/comments for next call.
   6. ACTION: Christine will add “Nurse Navigator” to the glossary as it compares to “Care Coordinator”.
   7. ACTION Marla to provide Helen to generic drug names so we don’t use brand names in the use case.
6. Review and approve Notice of Intent to Ballot (for May 2010 ballot cycle).
7. Project Team representation
   1. Do we have enough of the right people participating in this project?
   2. What "industries" do we have represented?
   3. What countries do we have represented?
8. Document Review Session
   1. Storyboard
   2. Glossary
   3. Direct Care Section (DC.1 to DC.1.5)
9. Decision on document review for next 2 weeks.
10. Other business
11. Agenda for next meeting:
    • NCI caBIG project use of standards discussion
      • Guest: Dr. Juli Klemm, Associate Director, Integrative Cancer Research Products and Programs, NCI Center for Bioinformatics
      • Guest: John Speakman, Associate Director, Clinical Products and Programs, NCI Center for Biomedical Informatics and Information Technology
12. Meeting adjourn